0.07Open0.07Pre Close0 Volume745 Open Interest67.00Strike Price0.00Turnover103.07%IV15.32%PremiumMay 9, 2025Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.07Extrinsic Value100Contract SizeAmericanOptions Type-0.0260Delta0.0088Gamma1129.14Leverage Ratio-0.0572Theta-0.0001Rho-29.32Eff Leverage0.0040Vega
Merck & Co Stock Discussion
For the revenue consensus estimate, analysts anticipate revenue around $15.48 billion, which would be a slight decrease of about 1.9% year-over-year.
Wall Street expects Merck to report EPS of approximately $2.16. This would r...
Landmark Trial: Merck's New PAH Drug Shows Stunning 76% Reduction in Life-Threatening Events
No comment yet